DEPARTMENT PROFILE

HOYNG ROKH MONEGIER

Life Sciences

Band 2Europe-wideEurope 2021 View ranking table
chambers review
department information
chambers review
department information

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

What the team is known for

Well-regarded IP boutique with strong offerings in the Netherlands, Spain and Belgium. Particularly respected for its patent litigation on behalf of leading pharmaceutical and biotechnology companies. Additionally offers regulatory strength, assisting clients with questions relating to market exclusivity, parallel import and regulatory data protection. Further strength in enforcement of rights and cases relating to biosimilars.

Strengths

A source praises the firm's "international reach, European experience and responsiveness."

"They work really well with their own network of offices in Europe; everything is supervised from their headquarters," enthuses a client, who adds: "They prepare themselves really accurately and co-ordinate themselves outstandingly with their international network. They have good bench depth."

Notable practitioners

Key contacts in the firm's life sciences group are Carla Schoonderbeek, based in Amsterdam, Liesbeth Weynants in Brussels, Luis Fernández-Novoa in Madrid and Benoît Strowel, who divides his time between Paris and Brussels.

Department Information

This content is provided by HOYNG ROKH MONEGIER.

Overview



HOYNG ROKH MONEGIER has a long history of working with innovative pharmaceutical companies to protect and maximize their intellectual property rights and assets. Our top-tier litigators help many of the world's largest pharmaceutical companies achieve their goals by advising on and litigating issues relating to patent and SPC infringement and validity, regulatory data protection, theft of trade secrets, antitrust violations, trade marks and advertising.

We also act for innovative clients of all sizes, from global leaders to small start-ups, in the medical devices and diagnostics sector. 

Our Life Sciences Regulatory practice covers all aspects of the development of medicinal products and medical devices. We advise on clinical trials (GCP), market authorisations, regulatory exclusivity, manufacturing (GMP), supply chain management, pharmaco- and materiovigilance, distribution, marketing and promotion, compliance, relationships with healthcare professionals, market access (in particular pricing and reimbursement strategies), patient support programmes, parallel trade, tenders, and privacy and data protection.

We advise and represent clients in their dealings with EU and national regulatory authorities and, if necessary, before the EU and national courts. For many years, we have represented the headquarters and local entities of a number of global pharmaceutical and biotech companies in EU and cross-border litigation and coordinated their legal representation across the EU.



Members

Köhler, Martin (Head of Department)

Breuer, Mathis

Haft, Klaus

Hahn, Tobias

Hessel, Tobias J.

Kanz, Christine

Kasper, Kay

Misgaiski, Thomas

Osterrieth, Christian

Richter, Stefan

Schmitz, Thomas H.

Stolzenbrug-Wiemer, Sandra

Tenbrock, Christina

Weinert, Mirko

Industries

Aerospace, automotive & marine

Biotechnology & Biologics

Chemicals

Electronics, computers, software & semiconductors

Fashion & Luxury goods

Industrial equipment & Manufacturing

Media

Medical devices

Pharmaceuticals

Retail & Consumer goods

Telecommunications & Networks

Life Sciences Department

HOYNG ROKH MONEGIER

firm
Department location

Rembrandt Tower, 30th floor

Amstelplein 1

Amsterdam

North Holland

Netherlands

1096 HA

View Firm Profile